We are witnessing an exponential increase in the use of different nanomaterials in a plethora of biomedical fields. We are all aware of how nanoparticles (NPs) have influenced and revolutionized the way we supply drugs or how to use them as therapeutic agents thanks to their tunable physico-chemical properties. However, there is still a niche of applications where NP have not yet been widely explored. This is the field of ocular delivery and NP-based therapy, which characterizes the topic of the current review. In particular, many efforts are being made to develop nanosystems capable of reaching deeper sections of the eye such as the retina. Particular attention will be given here to noble metal (gold and silver), and to polymeric nanoparti...
The complex network of neuronal cells in the retina makes it a potential target of neuronal toxicity...
Retinal degeneration refers to the pathological conditions affecting the ocular posterior segment, i...
Obtaining nano carriers capable of transporting antibodies that allow a longer residence time of dru...
We are witnessing an exponential increase in the use of different nanomaterials in a plethora of bio...
The clinical application of nanotechnology in medicine is promising for therapeutic, diagnostic, and...
AbstractWe are approaching a new era of retinal pharmacotherapy where new drugs are rapidly being wo...
This work has elucidated the potential of bio-inspired lipid nanoparticles for targeted retinal drug...
Neurodegenerations are a complex pool of diseases united by a progressive loss of neuronal cells. Re...
Nanoparticles are nanometer-scaled particles, and can be utilized in the form of nanocapsules, nanoc...
The retina maintains homeostasis through the blood-retinal barrier (BRB). Although it is ideal to de...
Despite numerous efforts, ocular drug delivery still remains a challenge for pharmaceutical scientis...
Particulate systems like micro/nanoparticles have been used as a physical approach to modify the pha...
The vitreous humor is the first barrier encountered by intravitreally injected nanoparticles. Lipid-...
Diabetic retinopathy (DR) is a major complication of diabetes, characterized by extensive vascular p...
Despite the higher rate of blindness due to population aging, minimally invasive and selective drug ...
The complex network of neuronal cells in the retina makes it a potential target of neuronal toxicity...
Retinal degeneration refers to the pathological conditions affecting the ocular posterior segment, i...
Obtaining nano carriers capable of transporting antibodies that allow a longer residence time of dru...
We are witnessing an exponential increase in the use of different nanomaterials in a plethora of bio...
The clinical application of nanotechnology in medicine is promising for therapeutic, diagnostic, and...
AbstractWe are approaching a new era of retinal pharmacotherapy where new drugs are rapidly being wo...
This work has elucidated the potential of bio-inspired lipid nanoparticles for targeted retinal drug...
Neurodegenerations are a complex pool of diseases united by a progressive loss of neuronal cells. Re...
Nanoparticles are nanometer-scaled particles, and can be utilized in the form of nanocapsules, nanoc...
The retina maintains homeostasis through the blood-retinal barrier (BRB). Although it is ideal to de...
Despite numerous efforts, ocular drug delivery still remains a challenge for pharmaceutical scientis...
Particulate systems like micro/nanoparticles have been used as a physical approach to modify the pha...
The vitreous humor is the first barrier encountered by intravitreally injected nanoparticles. Lipid-...
Diabetic retinopathy (DR) is a major complication of diabetes, characterized by extensive vascular p...
Despite the higher rate of blindness due to population aging, minimally invasive and selective drug ...
The complex network of neuronal cells in the retina makes it a potential target of neuronal toxicity...
Retinal degeneration refers to the pathological conditions affecting the ocular posterior segment, i...
Obtaining nano carriers capable of transporting antibodies that allow a longer residence time of dru...